New York State Department of Health HIV Uninsured Care Programs
|
|
- Gyles May
- 6 years ago
- Views:
Transcription
1 New York State Department of Health HIV Uninsured Care Programs AIDS Drug Assistance Program (ADAP) ADAP Plus (Ambulatory Care) HIV Home Care ADAP Plus Insurance Continuation (APIC) Lanny T. Cross Program Director Empire Station P.O. Box 2052 Albany, NY
2 New York State HIV Uninsured Care Programs Mission To provide access to care for all New York residents with HIV Dual Goals 1. To empower individuals with access to care 2. To provide a stable funding stream for providers
3 HIV Health Care Funding New York State Medicaid Enhanced Rates Primary Care Acute Care Long Term Care Foster Care Case Management Special Needs Plan (SNPs) Spenddown "Buy-In" Program Medicare HIV Uninsured Care Programs ADAP ADAP Plus HIV Home Care Grants Developmental Infrastructure Clinical Education Support Services Special Populations Corrections Veterans
4 New York State HIV Uninsured Care Programs Key Features Inclusive eligibility criteria User friendly Confidentiality Comprehensive formulary and continuum of ambulatory care Broad network of providers Provider friendly Medicaid compatibility Advisory Workgroup for community involvement Cooperative funding Centralized administration/operation
5 HIV Uninsured Care Programs Eligibility Criteria Residency = NYS Medical Financial ADAP & ADAP Plus = HIV+ Home Care = HIV illness or AIDS, and chronic medical dependency Income < $44,000/year for household of 1 Liquid Assets < $25,000
6 New York State AIDS Drug Assistance Program Formulary (more than 450 drugs as of 12/31/03) Antiretroviral Drugs Nucleoside Analogs -10 NNRTIs - 3 Fusion Inhibitor - 1 Protease Inhibitors - 7 RRI - 1 PCP Prophylaxis & Treatment - 9 Anti-Neoplastics - 16 Treatments for Opportunistic Infections - 45 Treatments for HIV/AIDS Related Conditions - 16 General Medications Antibiotics - 43 Gastrointestional - 15 Analgesics - 21 Insulin and related drugs - 13 Anti-diarrheals/malabsorption - 6 Bronchodilator/Respiratory Inhalants - 22 Psychotropics/anticonvulsants - 60 Hepatitis C - 1 Topical Steroids - 33 Hematology - 4 Sinusitis Medications - 49 Urinary Incontinance - 3 Cardiac Medications - 70 Ophthalmology - 34 Hyperlipidemia - 12 Gynecological - 3
7 UNINSURED CARE PROGRAMS COVERED SERVICES ADAP PLUS Services Comprehensive Medical Evaluation Disease Monitoring - Routine/Intermediate Visits Drug Administration Transfusions Clinic Visits & Physician Visits Primary Care OB/GYN Directly Observed Therapy Neurological Pediatric Ophthalmological Dermatology Specialty Medicine Dental & Oral Surgery Family Planning Oncology Mental Health (24 visits) Nutritional Assessment and Counseling Other Services Ambulatory Surgery Oral Nutritional Supplements Vitamins and Minerals (selected list) Laboratory Services (selected list) Viral Load Test Resistance Test (genotype & phenotype)
8 UNINSURED CARE PROGRAMS COVERED SERVICES HOME CARE PROGRAM Skilled Nursing Home Health Aide Homemaker Service Personal Care Aide IV Therapy Administration & Supplies Nutritional Assessment and Counseling Adult Day Health Care Limited Rehabilitative Therapy Durable Medical Equipment Note: A maximum lifetime benefit of $30,000 for home care services is allowed. EXCLUDED SERVICES Emergency Room Inpatient Services Pharmacy (Drugs not covered through ADAP) Ancillary Services - Any service, lab or procedure not included in the clinic visit. Rehabilitative Therapy (Vocational, Physical, Speech, etc.) Counseling & Testing Substance Abuse & Alcoholism Services/ Methadone Maintenance Case Management/Social Work Psychiatric/Mental Health (Extended visits)
9 ADAP Plus Insurance Continuation APIC Implemented on 7/1/00 Pays the insurance premiums of individuals who: Are unemployed and eligible to continue their insurance (COBRA) Are employed but the premium cost is a barrier to continuation Have self-pay insurance Eligibility: Residency, Financial & Medical = same as ADAP Cost effective insurance policy = individual assessment Premium cost is a barrier = premium versus income test Quality of coverage assessment If employed and eligible for work related insurance coverage: Employer must contribute more than 50% of premium
10 AIDS Deaths in New York State Residents ,000 8,446 8,419 Number of Cases Living 8,000 6,000 4,000 5,215 6,182 6,902 7,229 5,944 3,079 2,000 2,326 2,400 2,305 2,098 1, * 2001* Source: Bureau of Biometrics/NYSDOH *2002 data is provisional
11 Number of Cases Alive With AIDS at the End of Each Year, by Sex, New York State Number of Cases Living * Data as of May 2003 Males Females NYSDOH/BHAE
12 New York State - ADAP Active Enrollment 20 Thousands /96 6/96 7/96 8/96 9/96 10/96 11/96 12/96 1/97 2/97 3/97 4/97 5/97 6/97 7/97 8/97 9/97 10/97 11/97 12/97 1/98 2/98 3/98 4/98 5/98 6/98 7/98 8/98 9/98 10/98 11/98 12/98 1/99 2/99 3/99 4/99 5/99 6/99 7/99 8/99 9/99 10/99 11/99 12/99 1/00 2/00 3/00 4/00 5/00 6/00 7/00 8/00 9/00 10/00 11/00 12/00 1/01 2/01 3/01 4/01 5/01 6/01 7/01 8/01 9/01 10/01 11/01 12/01 1/02 2/02 3/02 4/02 5/02 6/02 7/02 8/02 9/02 10/02 11/02 12/02 1/03 2/03 3/03 4/03 5/03 6/03 7/03 8/03 9/03 10/03 11/ /04 2/04 3/04 4/04 1st day of each month enrollment Month/Year AENBYMO.PRS
13 New York State AIDS Drug Assistance Program Gender by Year of Enrollment 100% 80% 60% 40% 20% 0% MALE FEMALE October December 2003
14 NYS ADAP - Length of Stay Participants Enrolled in % 8% Percent of Enrollees 6% 4% 2% 0% Month Periods Males Females 72% of participants were still active on 12/31/2003
15 ADAP RACE/ETHNICITY Race/Ethnicity By Year of Enrollment 100% 80% 60% 40% 20% 0% October December 2003 WHITE HISPANIC AFRICAN AMERICAN OTHER/UNKNOWN
16 Users by Month - January 1995 through March 2004 Users by Month - Nucleoside Analogs, OI Meds, Protease Inhibitors and All Drugs 14 Thousands Jan-95 Feb-95 Mar-95 Apr-95 May-95 Jun-95 Jul-95 Aug-95 Sep-95 Oct-95 Nov-95 Dec-95 Jan-96 Feb-96 Mar-96 Apr-96 May-96 Jun-96 Jul-96 Aug-96 Sep-96 Oct-96 Nov-96 Dec-96 Jan-97 Feb-97 Mar-97 Apr-97 May-97 Jun-97 Jul-97 Aug-97 Sep-97 Oct-97 Nov-97 Dec -97 Jan -98 Feb -98 Mar -98 Apr -98 May -98 Jun -98 Jul -98 Aug -98 Sep -98 Oct -98 Nov -98 Dec -98 Jan -99 Feb -99 Mar -99 Apr -99 May -99 Jun -99 Jul -99 Aug -99 Sep -99 Oct -99 Nov -99 Dec -99 Jan -00 Feb -00 Mar -00 Apr -00 May -00 Jun -00 Jul -00 Aug -00 Sep -00 Oct -00 Nov -00 Dec -00 Jan -01 Feb -01 Mar -01 Apr -01 May -01 Jun -01 Jul -01 Aug -01 Sep -01 Oct -01 Nov -01 Dec -01 Jan -02 Feb -02 Mar -02 Apr -02 May -02 Jun -02 Jul -02 Aug -02 Sep -02 Oct -02 Nov -02 Dec -02 Jan -03 Feb -03 Mar -03 Apr -03 May -03 Jun -03 Jul -03 Aug -03 Sep -03 Oct -03 Nov -03 Dec -03 Jan -04 Feb -04 Mar -04 Nucleoside Analogs OI Meds Protease Inhibitors NNRTIs Fusion Inhibitors Total All Drugs Formulary Changes: 1/1/96 - Reduction; 7/1/96 - Protease Inhibitors added; 9/1/96 - General Meds restored; 12/1/96 - Restored remaining drugs
17 Government and Community Partnership on Drug Pricing Fair Pricing Coalition Treatment advocates and government payors Engage senior management of drug companies in pricing discussions Primary focus on initial pricing of new drugs and price freezes ADAP Crisis Task Force 10 ADAP/AIDS Directors representing 70% of the buying power of ADAPs Negotiated pricing concessions with all eight antiretroviral drug manufacturers $60M - $65M savings to ADAPs nationally from first round All ADAPs benefit equally Coordinate efforts with the Fair Pricing Coalition and other advocacy groups Continuation and expansion of efforts to secure the best possible price for ADAPs
18 NRTIs & NNRTIs - By FDA Approval Date $450 $400 $350 $300 $250 $200 $150 $100 $50 $0 RETROVIR VIDEX EC HIVID ZERIT EPIVIR VIRAMUNE RESCRIPTOR SUSTIVA ZIAGEN VIREAD EMTRIVA AWP-12% Net Cost
19 Protease & Entry Inhibitors by FDA Approval Date $4,000 $3,500 $3,000 $2,500 $2,000 $1,500 $1,000 $500 $0 FORTOVASE NORVIR CRIXIVAN VIRACEPT AGENERASE KALETRA FUZEON REYATAZ LEXIVA AWP-12% Net Cost
20 $60 Millions New York State ADAP Expense by Quarter of ADAP Costs Period April 1996 through March 2004 $50 $40 $30 $20 $10 $0 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q NA PI NNRTI Fusion Inhibitors All Other Protease Inhibitors added on 7/1/96 Non Nucloeoside Reverse Transcriptase Inhibitors (NNRTI) added 9/1/96) Fusion Inhibitors added 5/15/03
21 Primary Care Users by Month 6000 Number of Users Jan-95 Feb-95 Mar-95 Apr-95 May-95 Jun-95 Jul-95 Aug-95 Sep-95 Oct-95 Nov-95 Dec-95 Jan-96 Feb-96 Mar-96 Apr-96 May-96 Jun-96 Jul-96 Aug-96 Sep-96 Oct-96 Nov-96 Dec-96 Jan-97 Feb-97 Mar-97 Apr-97 May-97 Jun-97 Jul-97 Aug-97 Sep-97 Oct-97 Nov-97 Dec-97 Jan -98 Feb -98 Mar -98 Apr-98 May-98 Jun-98 Jul-98 Aug-98 Sep-98 Oct -98 Nov -98 Dec -98 Jan -99 Feb -99 Mar -99 Apr -99 May -99 Jun -99 Jul -99 Aug -99 Sep -99 Oct -99 Nov -99 Dec -99 Jan -00 Feb -00 Mar -00 Apr -00 May -00 Jun -00 Jul -00 Aug -00 Sep -00 Oct -00 Nov -00 Dec -00 Jan -01 Feb -01 Mar -01 Apr -01 May -01 Jun -01 Jul -01 Aug -01 Sep -01 Oct -01 Nov -01 Dec -01 Jan -02 Feb -02 Mar -02 Apr -02 May -02 Jun -02 Jul -02 Aug -02 Sep -02 Oct -02 Nov -02 Dec -02 Jan -03 Feb -03 Mar -03 Apr -03 May -03 Jun -03 Jul -03 Aug -03 Sep -03 Oct -03 Nov -03 Dec -03 Month-Year Updated: 04/12/04
22 Home Care Users by Month Number of Users Jan-95 Feb-95 Mar-95 Apr-95 May-95 Jun-95 Jul-95 Aug-95 Sep-95 Oct-95 Nov-95 Dec-95 Jan-96 Feb-96 Mar-96 Apr-96 May-96 Jun-96 Jul-96 Aug-96 Sep-96 Oct-96 Nov-96 Dec-96 Jan-97 Feb-97 Mar-97 Apr-97 May-97 Jun-97 Jul-97 Aug-97 Sep-97 Oct-97 Nov-97 Dec-97 Jan-98 Feb-98 Mar-98 Apr-98 May-98 Jun-98 Jul-98 Aug-98 Sep-98 Oct-98 Nov-98 Dec-98 Jan-99 Feb-99 Mar-99 Apr-99 May-99 Jun-99 Jul-99 Aug-99 Sep-99 Oct-99 Nov-99 Dec-99 Jan-00 Feb-00 Mar-00 Apr-00 May-00 Jun-00 Jul -00 Aug -00 Sep -00 Oct -00 Nov -00 Dec -00 Jan-01 Feb-01 Mar-01 Apr-01 May-01 Jun-01 Jul-01 Aug-01 Sep-01 Oct-01 Nov-01 Dec-01 Jan-02 Feb-02 Mar-02 Apr-02 May-02 Jun-02 Jul-02 Aug-02 Sep-02 Oct-02 Nov-02 Dec-02 Jan-03 Feb-03 Mar-03 Apr-03 May-03 Jun-03 Jul-03 Aug-03 Sep-03 Oct-03 Nov-03 Dec-03 Month-Year Updated: 04/12/04
23 HIV UNINSURED CARE PROGRAMS ACTUAL EXPENDITURES by QUARTER/YEAR 1996-Present $60 Millions $50 $40 $30 $20 $10 $0 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q HOME CARE ADAP PLUS ADAP APIC HUCPEX97
24 New York State ADAP Cost Containment Principles Do the least clinical harm Maintain HIV health care infrastructure Consistency with Program Principles - whenever possible Spread the Pain Reversible measures if fiscal situation changes Tiered approach for phased implementation Administrative Factors = Ease, speed and cost of implementation Avoid unintended consequences
25 New York State ADAP Cost Containment Contingency Plan Developed by Clinical Subcommittee 7 $5 M/Tier for Phased Implemenation Tiers 1 to 4 recommended by Steering Committee Restrictions and Elimination of Drugs and Services Reduced Payments to Providers Restrictions on Eligibility
26 New York State ADAP Cost Containment Contingency Plan (continued) Tier 1 - Implementation date = 02/15/03 Limit number of clinic and dental visits per year Limit refills to 5 per prescription, and encourage participants to avoid unnecessary filling of prescriptions Mandatory generics Begin restructuring of coverage of nutritional supplements by restricting daily quantity limits. Eliminate certain high cost drugs, where there are less expensive alternatives Encourage participants to apply for other coverage (Medicaid, Medicaid Spenddown, Family Health Plus, etc.)
27 New York State ADAP Cost Containment Contingency Plan (continued) Tier 2 Tier 3 Tier 4 Reduction in payments to pharmacies and health care providers Further restructuring of nutritional coverage, and Elimination of coverage of lower priority drugs and categories of drugs Further reductions in payments to pharmacies and providers Further reduction and restriction of formulary, and Restrictions on coverage of participants with partial insurance Major reductions to formulary and covered services
28 New York State AIDS Drug Assistance Program Regained financial stability Program Status 4/1/04 Deferred implementation of the remaining cost containment tiers Expanded the formulary and covered services in high priority areas: New antiretrovirals - Fuzeon, Emtriva, Reyataz and Lexiva Hepatitis C - pegylated interferon and ribavirin, viral load and genotype tests Voriconazole for fungal infections Testosterone gel (Androgel and Testim) for wasting syndrome New psychotropics - aripiprazole, escitalopram, ziprasidone HCL New anticonvulsant - oxcarbazepine
29 New York State AIDS Drug Assistance Program Future Continued growth in enrollment with: Inclusive eligibility criteria Comprehensive outreach program Further refinement of drug and service coverage to address emerging HIV related conditions Unknowns Medicare Prescription Coverage Medicaid Reform Federal Funding Ryan White CARE Act Reauthorization
Genotyping and Drug Resistance in Clinical Practice. Case Studies
Genotyping and Drug Resistance in Clinical Practice Case Studies 12/02 40 year old Hispanic male Dx with HIV 1995 + Hx of PCP > 1x, HepC Medication history: AZT, Crixivan, Videx EC, Sustiva, Zerit, Ziagen,
More informationOB/GYN CHART REVIEW DRAFT: NOT FOR DISTRTIBUTION
OB/GYN CHART REVIEW A summary of OB/GYN clinical chart review results designed to monitor the quality of care provided by a Ryan White funded OB/GYN primary care site as part of the Atlanta EMA s quality
More informationAIDS Drug Assistance Program ADAP-Miami. NEEDS ASSESSMENT July 16, 2010
AIDS Drug Assistance Program ADAP-Miami NEEDS ASSESSMENT July 16, 2010 ADAP Clients - Gender ADAP Clients by Gender FY 09/10 April 2010 to June 2010 26% 0% Males Females 26% 0% Males Females Transgender
More informationADAP Monitoring Provider Prescribing Patterns. Amanda Bowes, NASTAD Christine Rivera and Dr. Charles Gonzalez, NYS AIDS Institute
ADAP Monitoring Provider Prescribing Patterns Amanda Bowes, NASTAD Christine Rivera and Dr. Charles Gonzalez, NYS AIDS Institute WEBINAR ETIQUETTE All questions or comments can be shared either via the
More informationPositive Living Conference
Positive Living Conference Ft. Walton Beach, Thomas Liberti Chief, Bureau of HIV/AIDS Department of Health March 11, 2011 Tallahassee, 1 The Epidemic in, 2010 60% White Population: 18.8 million (4 th 16%
More informationMidwestern Underwriting Conference 2016
UNDERWRITING HIV: THE FAIRY TALE HAS BECOME REALITY Midwestern Underwriting Conference 2016 Jean-Marc Fix, FSA, MAAA VP, R&D, Optimum Re Insurance Co. AGENDA Where are we with HIV? The risk The ideal case
More informationLesson 3: HIV Poverty
Video Curriculum Modules Lesson 3: HIV Poverty 47 Lesson 3: Poverty Standards: Health: 1.12.2 1.12.3 1.12.6 2.12.4 2.12.10 5.12.2 5.12.4 8.12.1 8.12.3 Science: 7.1 7.5 7.6 8.2 8.3 Overview Poverty has
More informationSubstance Abuse Services. AIDS Drug Assistance. Oral Health Care. Program (ADAP) Medical Care
2017-2018 Council for HIV/AIDS Care and Prevention Core Medical Service Area Paired Comparison Analysis Prioritization Worksheet Medical Case Management Services Substance Abuse Services - Outpatient AIDS
More informationHealth Care Reform Update and Advocacy Priorities
Health Care Reform Update and Advocacy Priorities Robert Greenwald Clinical Professor of Law Director, Center for Health Law and Policy Innovation of Harvard Law School October 2012 PRESENTATION OUTLINE
More information2
1 2 3 4 5 6 7 8 9 ADAP client enrollment and client utilization reached their highest levels during FY2010. However, as a result of the national fiscal crisis and implementation of cost-containment measures,
More informationAccess to Care and Treatment for HCV Mono-Infection and HIV/HCV Co-Infection
Access to Care and Treatment for HCV Mono-Infection and HIV/HCV Co-Infection Chris Taylor, Director, Viral Hepatitis Britten Pund, Senior Manager, Health Care Access Amanda Bowes, Associate, Health Care
More information0.14 ( 0.053%) UNAIDS 10% (94) ( ) (73-94/6 ) 8,920
0.14 UNAIDS 0.053% 2 250 60 10% 94 73 20 73-94/6 8,920 12 43 Public Health Service Task Force Recommendations 5-10% for Use of Antiretroviral Drugs in 10-20% Pregnant HIV-1-Infected Women for Maternal
More informationMEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 03/07/18 SECTION: DRUGS LAST REVIEW DATE: 02/19/19 LAST CRITERIA REVISION DATE: ARCHIVE DATE:
FUZEON (enfuvirtide) Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs
More informationTHE EARLY TREATMENT FOR HIV ACT: MEDICAID COVERAGE FOR PEOPLE LIVING WITH HIV
THE EARLY TREATMENT FOR HIV ACT: MEDICAID COVERAGE FOR PEOPLE LIVING WITH HIV INTRODUCTION The Early Treatment for HIV Act (ETHA) would allow states to extend Medicaid coverage to uninsured, non-disabled
More informationHIV and YOU. Special 2008 Update!
HIV and YOU Special 2008 Update! HIV and You Special 2008 Update! In this booklet, you ll see words in bold, red type. Go to the Glossary on the back cover to find out what these words mean. WRITERS AND
More informationU.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs
U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs Michelle Van Handel, MPH Health Scientist National Center for HIV/AIDS, Viral Hepatitis, STDs and
More informationHIV Drugs and the HIV Lifecycle
HIV Drugs and the HIV Lifecycle Together, we can change the course of the HIV epidemic one woman at a time. #onewomanatatime #thewellproject All HIV drugs work by interrupting different steps in HIV's
More informationTHE HIV LIFE CYCLE. Understanding How Antiretroviral Medications Work
THE HIV LIFE CYCLE Understanding How Antiretroviral Medications Work DEFINITIONS Host: The animal or cell that another organism lives in. In HIV human CD4 T-cells are the host for HIV. Nucleus: The core
More informationCost projections a single antiretroviral co-payment scheme for people with HIV in NSW. March 2013
Cost projections a single antiretroviral co-payment scheme for people with HIV in NSW March 2013 Background The first meeting of HIV Strategy Implementation Taskforce Committee endorsed a policy position
More informationResponding to HIV/AIDS in Illinois Remarks to the Adequate Health Care Task Force
Responding to HIV/AIDS in Illinois Remarks to the Adequate Health Care Task Force AIDS Foundation of Chicago June 27, 2006 AIDS-Related Deaths Since 1981 United States: 530,000 Illinois: 18,000 Chicago:
More informationGlobal Fund Approach to Health System Strengthening
Global Fund Approach to Health System Strengthening WHO Expert consultation on positive synergies between health systems and Global Health Initiatives Geneva, 29-30 May 2008 Dr Stefano Lazzari, Director
More informationHIV MEDICATIONS AT A GLANCE. Atripla 600/200/300 mg tablet tablet daily. Complera 200/25/300 mg tablet tablet daily
HIV MEDICATIONS AT A GLANCE Generic Name Trade Name Strength DIN Usual Dosage Single Tablet Regimen (STR) Products Efavirenz/ Emtricitabine/ rilpivirine/ elvitegravir/ cobicistat/ alafenamide Emtricitabine/
More informationALABAMA S ADAP FORMULARY OFFERS 117 MEDICATIONS
ALABAMA S ADAP FORMULARY OFFERS 117 MEDICATIONS - 2014 Alabama s ADAP formulary offers a minimum of one medication from each HIV antiretroviral class approved by the U.S. Food and Drug Administration (FDA).
More informationTerapia antirretroviral inicial y de rescate: Utilidad actual y futura de nuevos medicamentos
Terapia antirretroviral inicial y de rescate: Utilidad actual y futura de nuevos medicamentos (Antiretroviral Therapy Present and Future Prospects of Antiretroviral Drugs in Initial and Salvage Therapy)
More informationAn Examination of Access to HIV/AIDS Medications in Exchange Plans United States Conference on AIDS. September 10,
An Examination of Access to HIV/AIDS Medications in Exchange Plans United States Conference on AIDS September 10, 2015 www.avalere.com Agenda PlanScape Methodology Key Takeaways Access to HIV/AIDS Medications
More informationHIV THERAPY STRATEGIES FOR THIRD LINE. issues to consider when faced with few drug options
STRATEGIES FOR THIRD LINE HIV THERAPY issues to consider when faced with few drug options A PUBLICATION FROM Information, Inspiration and Advocacy for People Living With HIV/AIDS MAY 2008 Most people living
More informationRyan White CARE Act, Title II. AIDS Drug Assistance Program (ADAP) ADAP. The National FY Complete Projection, with slides - 27 Pages
The National ADAP Working Group An AIDS Drug Assistance Program Advocacy Coalition 1773 T Street, NW Washington, D.C. 20009 Ryan White CARE Act, Title II AIDS Drug Assistance Program (ADAP) Ph: (202) 588-1775
More informationHuangdao People's Hospital
Table of contents 1. Background... 3 2. Integrated care pathway implementation... 6 (1) Workload indicators... 6 A. In eligible for care pathway... 6 B. Care pathway implementation... 7 (2) Outcome indicators...
More informationThe Impact of Health Reform on Future Funding of HIV/AIDS Programs
The Impact of Health Reform on Future Funding of HIV/AIDS Programs Lindsey Dawson Outline The Domestic HIV Epidemic: Where we are today? The Impact of Health Reform: What can we expect? Impact of Health
More informationImpact of Sequestration on People Living with HIV/AIDS
Impact of Sequestration on People Living with HIV/AIDS N I N A R O T H S C H I L D, D R P H H I V H E A L T H A N D H U M A N S E R V I C E S P L A N N I N G C O U N C I L O F N E W Y O R K M A R C H 1
More informationHIV HEALTH & HUMAN SERVICES PLANNING COUNCIL OF NEW YORK Oral Health Care Directive - Tri-County Approved by the HIV Planning Council 3/31/16
1) To promote optimal health and quality of life resulting from the prevention, early detection and treatment of dental decay and periodontal disease, opportunistic infections, and other health-related
More informationDrug Treatment Program Update
Drug Treatment Program Update As of March 211 Drug Treatment Program Update A key component of the Centre s mandate is to monitor the impact of HIV/AIDS on British Columbia. The Centre provides essential
More informationFunding the Ryan White Program: Now and in the Future
Funding the Ryan White Program: Now and in the Future Carl Schmid United States Conference on AIDS San Diego, CA October 4, 2014 Outline The Fiscal Environment Recent Ryan White Funding Levels Impact of
More informationThe AIDS Drug Assistance Program Following the Epidemic: Past, Present, and Future
Introduction The AIDS Drug Assistance Program (ADAP) is a federally funded provider of medication for the treatment of HIV infection. Without this program, thousands of individuals who are uninsured or
More informationIOWA COALITION ON MENTAL HEALTH AND AGING. Policy and Administration Workgroup
IOWA COALITION ON MENTAL HEALTH AND AGING Policy and Administration Workgroup PRIMARY GOALS Make mental wellness a priority issue for policy makers Make mental wellness a priority among program administrators
More informationDMAS UPDATE ON GAP PROGRAM. Cindi B. Jones, Director, DMAS House Appropriations Committee September 18, 2017
DMAS UPDATE ON GAP PROGRAM Cindi B. Jones, Director, DMAS House Appropriations Committee September 18, 2017 Bridging the Mental Health Coverage GAP GAP s Inception The Governor s Access Plan 1 of a 10
More informationHIV medications HIV medication and schedule plan
Living with HIV (human immunodeficiency virus) It may be scary to find out that you re HIV-positive or have AIDS. Coping with this news may be difficult. Although HIV is a serious infection, people with
More informationHIV Drug Market by Medication class (multi-class combination drugs, nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse
HIV Drug Market by Medication class (multi-class combination drugs, nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs),
More informationRequiring premiums as well as instituting lockout periods and enrollment limits will increase the number of uninsured and result in barriers to care
July 14, 2017 The Honorable Tom Price, Secretary U.S. Department of Health and Human Services 200 Independence Avenue, SW Washington, DC 20201 Dear Secretary Price, We appreciate the opportunity to comment
More informationUsing Data to Measure Performance in Public Health Programs: The Ryan White HIV/AIDS Program
Slide #1 Using Data to Measure Performance in Public Health Programs: The Ryan White HIV/AIDS Program IOM Public Meeting #2 Committee to Review Data Systems for Monitoring HIV Care Faye E. Malitz, MS Director,
More informationEstimating the Impact of Medical Innovation: A Case Study of HIV Antiretroviral Treatments
University of Pennsylvania ScholarlyCommons Health Care Management Papers Wharton Faculty Research 1-2008 Estimating the Impact of Medical Innovation: A Case Study of HIV Antiretroviral Treatments Mark
More informationWOMEN'S INTERAGENCY HIV STUDY METABOLIC STUDY: MS01 SPECIMEN COLLECTION FORM
WOMEN'S INTERAGENCY HIV STUDY METABOLIC STUDY: MS01 SPECIMEN COLLECTION FORM ID LABEL HERE ---> VERSION DATE 10/01/07 - - - VISIT #: FORM COMPLETED BY: A1. DATE OF BLOOD DRAW: / / M D Y A2. Do you take
More information2017 National Medicaid & CHIP Oral Health Symposium. Non-Ventilator Pneumonia and Oral Health Natalia I. Chalmers, DDS, PhD
2017 National Medicaid & CHIP Oral Health Symposium Non-Ventilator Pneumonia and Oral Health Natalia I. Chalmers, DDS, PhD 1 Oral Health and Overall Health (Source: Philips ) 2 Oral Health and Overall
More informationUtilizing CQI to Improve the Health of Supportive Housing Residents The North American Housing and HIV/AIDS Research Summit VII September 25-27, 2013
Utilizing CQI to Improve the Health of Supportive Housing Residents The North American Housing and HIV/AIDS Research Summit VII September 25-27, 2013 Montréal, Canada MISSION To provide 100% access to
More informationState of Alabama AIDS Drug Assistance Program (ADAP) Quarterly Report
State of Alabama AIDS Drug Assistance Program (ADAP) Quarterly Report This report reflects active clients currently enrolled in ADAP Full-pay Prescription Program (ADAP-Rx), Alabama s Insurance Assistance
More informationWOMENS INTERAGENCY HIV STUDY ANTIRETROVIRAL DOSAGE FORM SECTION A. GENERAL INFORMATION
WOMENS INTERAGENCY HIV STUDY ANTIRETROVIRAL DOSAGE FORM SECTION A. GENERAL INFORMATION A1. PARTICIPANT ID: ENTER NUMBER HERE - - - ONLY IF ID LABEL IS NOT AVAILABLE A2. VISIT #: A3. VERSION DATE: 1 0 /
More informationThe CIDRZ Experience: use of data to understand patient outcomes and guide program implementation 07 January 2010
The CIDRZ Experience: use of data to understand patient outcomes and guide program implementation 07 January 2010 Dr C Bolton Moore Deputy Medical Director CIDRZ Ministry of Health Zambia University of
More informationThe Ryan White Comprehensive AIDS Resources Emergency (CARE) Act: A Side-by-Side Comparison of Current Law and Reauthorization Proposals
The Ryan White Comprehensive AIDS Resources Emergency (CARE) Act: A Side-by-Side Comparison of Current Law and Reauthorization Proposals june 2006 Jennifer Kates Kaiser Family Foundation The Ryan White
More informationPharmacy Trends and Management Opportunities. Kerry Bendel, R.Ph. Director of Pharmacy Medica
Pharmacy Trends and Management Opportunities Kerry Bendel, R.Ph. Director of Pharmacy Medica September 14, 20 1 Agenda Pharmacy Trend Experience Trend Drivers and Management Opportunities Call to Action
More informationSTRENGTHENING THE COORDINATION, DELIVERY AND MONITORING OF HIV AND AIDS SERVICES IN MALAWI THROUGH FAITH-BASED INSTITUTIONS.
STRENGTHENING THE COORDINATION, DELIVERY AND MONITORING OF HIV AND AIDS SERVICES IN MALAWI THROUGH FAITH-BASED INSTITUTIONS. Acknowledgements This project was fully funded by Center For Disease Control
More informationHEALTH CARE EXPENDITURES ASSOCIATED WITH PERSISTENT EMERGENCY DEPARTMENT USE: A MULTI-STATE ANALYSIS OF MEDICAID BENEFICIARIES
HEALTH CARE EXPENDITURES ASSOCIATED WITH PERSISTENT EMERGENCY DEPARTMENT USE: A MULTI-STATE ANALYSIS OF MEDICAID BENEFICIARIES Presented by Parul Agarwal, PhD MPH 1,2 Thomas K Bias, PhD 3 Usha Sambamoorthi,
More informationTHE AFFORDABLE CARE ACT AND HIV MAXIMIZING OPPORTUNITIES FOR COVERAGE AND CARE
THE AFFORDABLE CARE ACT AND HIV MAXIMIZING OPPORTUNITIES FOR COVERAGE AND CARE Jeffrey S. Crowley Distinguished Scholar/Program Director, National HIV/AIDS Initiative O Neill Institute for National and
More informationThe Affordable Care Act and HIV/AIDS: Implications for Coverage, Access to Care, and Payment
The Affordable Care Act and HIV/AIDS: Implications for Coverage, Access to Care, and Payment for National and Global Health Law Overview This is a unique moment in our Nation s response to the HIV epidemic.
More informationTri-County Opioid Safety Coalition Data Brief December 2017 Clackamas, Multnomah, and Washington Counties
Medicaid-Funded Alternative Treatment for Back Pain in the Tri-County Region Key Findings The percentage of members with a back pain diagnosis who received an alternative treatment increased from 29% in
More informationPotential disruption from private exchanges and narrow networks. In 2011, less than 10% of companies used High Performing Networks (narrow networks)
1 3 2 Potential disruption from private exchanges and narrow networks. In 2011, less than 10% of companies used High Performing Networks (narrow networks) and in 2014 estimated to be 40%. By 2018, that
More informationHIV Management in Russia
HIV Management in Russia Examining the infrastructure of the Russian and USA healthcare systems with respect to the management of HIV patients By The Global Virology Therapy Monitor Team, Ipsos Healthcare
More informationHIV THERAPY STRATEGIES FOR FIRST LINE. issues to think about when going on therapy for the first time
STRATEGIES FOR FIRST LINE HIV THERAPY issues to think about when going on therapy for the first time A PUBLICATION FROM Information, Inspiration and Advocacy for People Living With HIV/AIDS MAY 2008 Deciding
More informationImplementation of testing (and other interventions along the Continuum of Care)
Implementation of testing (and other interventions along the Continuum of Care) Jonathan Mermin, MD, MPH National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention U.S. Centers for Disease Control
More informationReducing COPD Exacerbation Readmissions in a Community-Based Teaching Hospital
Reducing COPD Exacerbation Readmissions in a Community-Based Teaching Hospital Dawn Waddell, PharmD, BCPS Clinical Pharmacy Manager Lisa Kingdon, PharmD, BCPS Clinical Pharmacy Specialist Dawn Waddell
More informationHIV Integrase Inhibitors: Current and Future Use. Douglas G. Fish, MD Albany Medical College Cali, Colombia March 13, 2008
HIV Integrase Inhibitors: Current and Future Use Douglas G. Fish, MD Albany Medical College Cali, Colombia March 13, 2008 Which of the following statements about raltegravir is false? a) Raltegravir is
More informationADAP Coverage of HCV Treatment Medications. Amanda Bowes November 29, 2017
ADAP Coverage of HCV Treatment Medications Amanda Bowes November 29, 2017 AGENDA Background National ADAP Formulary Database: HCV Coverage NASTAD Consultation: Strategies to Increase Hepatitis C Treatment
More informationHRSA HIV/AIDS Bureau Updates
HRSA HIV/AIDS Bureau Updates Minority AIDS Initiative (MAI): 15 Years Later What s Been Achieved? What Are the Ongoing Barriers to Success? October 2, 2014 Harold J. Phillips Deputy Director Division of
More informationCost-Effectiveness of Lung Volume Reduction Surgery
Cost-Effectiveness of Lung Volume Reduction Surgery The Health Industry Forum October 24, 2007 - Washington DC The National Emphysema Treatment Trial National Emphysema Treatment Trial (NETT) Multicenter,
More informationAppropriate Use & Safety Edits
Appropriate Use & Safety Edits Envolve Pharmacy Solutions provides a variety of safety edits to promote the use of the right medication, in the right patient, at the right time. These edits are routinely
More informationNational ADAP Monitoring Project Annual Report APRIL 2008 SUMMARY AND DETAILED FINDINGS
National ADAP Monitoring Project Annual Report APRIL 2008 SUMMARY AND DETAILED FINDINGS Acknowledgements The Henry J. Kaiser Family Foundation (Kaiser) and The National Alliance of State and Territorial
More informationTHE AFFORDABLE CARE ACT, MEDICAID & RYAN WHITE: THE HIV VOTE. Daniel Tietz, RN, JD Executive Director
THE AFFORDABLE CARE ACT, MEDICAID & RYAN WHITE: THE HIV VOTE Daniel Tietz, RN, JD Executive Director dtietz@acria.org Overview The Affordable Care Act and HIV Medicaid Expansion or not? Ryan White filling
More informationQuit Rates of New York State Smokers
Quit Rates of New York State Smokers Sara M. Abrams, MPH Data Manager NYS Smokers Quitline Sara.Abrams@roswellpark.org September 6, 20 Presentation Outline Basic Quitline Service How Quit Rates are defined
More informationOCTOBER 2011 MEDICAID AND HIV: A NATIONAL ANALYSIS
OCTOBER 2011 MEDICAID AND HIV: A NATIONAL ANALYSIS MEDICAID AND HIV: A NATIONAL ANALYSIS OCTOBER 2011 Prepared by JEN KATES EXECUTIVE SUMMARY Medicaid, the nation s principal safety-net health insurance
More informationKansas EMS Naloxone (Narcan) Administration
Kansas EMS Naloxone (Narcan) Administration Executive Summary Kansas Board of Emergency Medical Services August 217 The following pages denote an ongoing trending of naloxone administration by Kansas Emergency
More informationNASTAD AT-A-GLANCE. Britten Pund, Director, Health Care Access
NASTAD AT-A-GLANCE Britten Pund, Director, Health Care Access ABOUT NASTAD 2 WHO, WHAT, AND HOW Who is NASTAD? Leading non-partisan non-profit association representing public health officials who administer
More informationIllinois Department of Public Health Office of Health Protection HIV/AIDS Section
Illinois Department of Public Health Office of Health Protection HIV/AIDS Section HIV/AIDS Section Overview - AIDS Drug Assistance Program (ADAP) History and Implications to SFY 2013 HIV/AIDS GRF Lump
More informationDaclatasvir (Daklinza ) Drug Interactions with HIV Medications
Daclatasvir/Sofosbuvir (Daklinza /Sovaldi TM ) Drug Interactions A Quick Guide for Clinicians April 2017 John J Faragon, PharmD, BCPS, AAHIVP Mechanism of Action and Route of Metabolism for Daclatasvir
More informationJanuary 16, Dear Administrator Verma:
Ms. Seema Verma Administrator Centers for Medicare and Medicaid Services Department of Health and Human Services Attention: CMMI New Direction P.O. Box 8011 Baltimore, MD 21244-1850 Re: (CMS-4182-P) Medicare
More informationObstacles and Opportunities on Our Path Toward Eliminating Viral Hepatitis
Obstacles and Opportunities on Our Path Toward Eliminating Viral Hepatitis Jonathan Mermin, MD, MPH National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention Centers for Disease Control and
More informationIssues for Part D Compliance
HCCA- MEDICARE PRESCRIPTION DRUG PART D COMPLIANCE CONFERENCE Issues for Part D Compliance Craig Miner, RPh, JD Division of Drug Plan Policy Babette S. Edgar, Pharm.D., MBA Division of Finance and Operations
More informationCurators of the University of Missouri - Combined January 1, 2016 through December 31, 2016
Cost Management Report Delta Dental Network Coverage Network Utilization Discount Delta Dental PPO Network 28.3% 29.4% Delta Dental Premier Network 67.0% 12.0% Total 95.3% Savings Categories $ % of Net
More informationJill Davidson CEO SHine SA. On Line Chlamydia Initiative
Jill Davidson CEO SHine SA On Line Chlamydia Initiative Sexual and Reproductive Health STI and HIV services Family planning services 9 clinic sites (including 1 women s prison/2 men s prison Workforce
More informationRe: Impact of Prohibiting HIV Prescription Drug Co-pay Cards from Counting Towards Deductibles and Maximum Out-of-Pocket Expenses
May 16, 2018 Name Address Re: Impact of Prohibiting HIV Prescription Drug Co-pay Cards from Counting Towards Deductibles and Maximum Out-of-Pocket Expenses Dear : We the 60 undersigned organizations of
More informationJustifying New Oncology Pharmacist Positions
Faculty Disclosures Justifying New Oncology Pharmacist Positions I will not be discussing off-label uses of any medications I am on the speaker s bureau for Millenium Pharmaceuticals and am a paid consultant
More informationThe Opioid Addiction Emergency In Virginia June 8, 2017
The Opioid Addiction Emergency In Virginia June 8, 2017 Marissa J. Levine, MD MPH State Health Commissioner Virginia Department of Health Chronic Disease of Addiction Definition: A primary, chronic disease
More informationOrgan Donation Breakthrough Collaborative Institute of Medicine
Organ Donation Breakthrough Collaborative Institute of Medicine June 20, 2005 Jade Perdue, M.P.A Department of Health and Human Services Health Resources and Services Administration Healthcare Systems
More informationRyan White Part A Overview
Ryan White Part A Overview April 25, 2018 Dennis Brophy Director, Ryan White Services Division Learning Objectives Ryan White Grant Principles Ryan White Funding Status EMA Services Direction of Services
More informationOral Health Provisions in Recent Health Reform: Opportunities for Public-Private Partnerships
Oral Health Provisions in Recent Health Reform: Opportunities for Public-Private Partnerships 2010 National Primary Oral Health Conference Tuesday, October 26, 2010 Catherine M. Dunham, Executive Director
More informationNational ADAP Monitoring Project Annual Report SUMMARY AND DETAILED FINDINGS APRIL 2009
National ADAP Monitoring Project Annual Report SUMMARY AND DETAILED FINDINGS APRIL 2009 Acknowledgements The Henry J. Kaiser Family Foundation (KFF) and the National Alliance of State and Territorial AIDS
More informationAdherence Strategies for Older Adults. AIDS Community Research Initiative of America (ACRIA)
Adherence Strategies for Older Adults AIDS Community Research Initiative of America (ACRIA) June 2008 Modular Objectives By the end of the module, participants will be able to: Define adherence Be able
More informationRay County Memorial Hospital 2016 Implementation Plan 1
Ray County Memorial Hospital 2016 Implementation Plan 1 Ray County Memorial Hospital is a critical access health care facility located in Richmond, Missouri. Ray County Memorial Hospital provides inpatient
More informationNothing to disclose.
Lisa G. Winston, MD University of California, San Francisco San Francisco General Hospital HIV UPDATE FOR THE PRIMARY CARE PROVIDER Nothing to disclose. 1 Outline Epidemiology Screening / testing for HIV
More informationNON-OCCUPATIONAL POST EXPOSURE PREVENTION. when you think you were exposed to hiv within the past three days
NON-OCCUPATIONAL POST EXPOSURE PREVENTION when you think you were exposed to hiv within the past three days A PUBLICATION FROM Information, Inspiration and Advocacy for People Living With HIV/AIDS MAY
More informationDr. David Baker-Hargrove, PhD President/CEO Two Spirit Health Services LGBT Medical and Mental Health Clinic in Orlando, FL Lindsay Kincaide
Dr. David Baker-Hargrove, PhD President/CEO Two Spirit Health Services LGBT Medical and Mental Health Clinic in Orlando, FL Lindsay Kincaide Community Development Manager Hope and Help Center of Central
More informationARUBA RECENT ECONOMIC DEVELOPMENTS AND OUTLOOK. Presented by Jane R. Semeleer President Centrale Bank van Aruba May 30, 2011
ARUBA RECENT ECONOMIC DEVELOPMENTS AND OUTLOOK Presented by Jane R. Semeleer President Centrale Bank van Aruba May 30, 2011 STRUCTURE 1. National economy 2. International economy 3. Outlook 2 CENTRALE
More informationFlexRx 6-Tier. SM Pharmacy Benefit Guide
FlexRx 6-Tier SM Pharmacy Benefit Guide Welcome to FlexRx The AllWays Health Partners FlexRx SM program is built for choice, savings, and convenience with benefits including: Low-cost drug tier for many
More informationNCC Pediatrics Continuity Clinic Curriculum: Medical Home Module 2 Well Visits
NCC Pediatrics Continuity Clinic Curriculum: Medical Home Module 2 Well Visits Overall Goal: To identify strategies for providing comprehensive care during a well visit. The provision of comprehensive
More informationEmergency Department Boarding of Psychiatric Patients in Oregon
College of Public Health and Human Sciences Emergency Department Boarding of Psychiatric Patients in Oregon Jangho Yoon, PhD, Jeff Luck, PhD April 25, 2017 Scope Quantify the extent of psychiatric emergency
More informationCHAPTER FOUR: UPDATE ON THE AIDS PANDEMIC TABLE 2 MILESTONES IN THE HISTORY OF HIV/AIDS TABLE 2 (CONTINUED) REGIONAL OVERVIEW...
CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR DOING THE STUDY... 1 SCOPE OF REPORT... 1 MARKET ANALYSES AND FORECASTS... 2 INTENDED AUDIENCE... 2 INFORMATION SOURCES... 2 ANALYST
More informationUPDATE: Screening and Coverage for Diabetes and Prediabetes. Karin Gillespie, Changing Diabetes Policy, Novo Nordisk
UPDATE: Screening and Coverage for Diabetes and Prediabetes Karin Gillespie, Changing Diabetes Policy, Novo Nordisk 2 USPSTF Diabetes Screening Guideline New USPSTF Abnormal Blood Glucose and Type 2 Diabetes
More information5/2/2016. Dr Brooks has no relevant financial affiliations to disclose. (Update 04/15/16) Learning Objectives
Persistent Challenge of HIV Transmission Control in Injection Drug Use: The Indiana Outbreak John T. Brooks, MD Senior Medical Advisor, Division of HIV/AIDS Prevention National Center for HIV/AIDS, Viral
More informationTB Nurse Case Management
TB Nurse Case Management San Antonio, Texas March 2-4, 2011 Discovering Social Service Networks for Your TB Patients Mary Long, MSPH March 3, 2011 Mary Long, MSPH has the following disclosures to make:
More information